ASK Company, the parent organization of RIMAN, has launched a prestigious sponsored research collaboration with the Mitragotri Laboratory at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). This partnership aims to scientifically validate and advance the understanding of Araliadiol, a proprietary ingredient exclusive to the brand.
Araliadiol is a unique compound derived from Giant BYoungPool. While previous studies with Sungkyunkwan and Konkuk Universities established their cell-protective effects, this new phase focuses on global scalability and advanced biological validation.
Key Research Objectives:
The collaboration will utilize organ-on-a-chip technology, a revolutionary biomimetic platform. This technology replicates human physiological environments on microchips, allowing researchers to:
A formal ceremony at the Harvard Science & Engineering Complex marked the start of the project. Attendees included Professor Samir Mitragotri, a leading expert in bioengineering, and RIMAN Founder & Chairman Joonghyun Ahn.
“This research collaboration marks a significant milestone in our R&D journey. We aim to establish Araliadiol as a premier functional ingredient in the global beauty market.” Joonghyun Ahn, Founder & Chairman
By partnering with world-class institutions like Harvard, ASK Company is positioning RIMAN as a science-first leader. This initiative not only strengthens their proprietary technology but also sets a new benchmark for evidence-based skincare and wellness products.
There are no reviews yet. Be the first one to write one.
